Cas:2153-26-6 Terpinyl formate manufacturer & supplier

Chemical Name:Terpinyl formate

CAS.NO:2153-26-6

Synonyms:p-Menth-1-en-8-ylformiat;p-menth-1-en-8-ylformate;Formic acid p-menth-1-en-8-yl ester;FEMA 3052;p-1-Menthen-8-ylformate;Ameisensaeure-p-menth-1-en-8-ylester

Molecular Formula:C₁₁H₁₈O₂

Molecular Weight:182.25900

HS Code:2915120000

Physical and Chemical Properties:

Melting point:N/A

Boiling point:220ºC(lit.)

Density:0.981 g/mL at 25ºC(lit.)

Index of Refraction:n20/D 1.471(lit.)

PSA:26.30000

Exact Mass:182.13100

LogP:3.32030

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like p-Menth-1-en-8-ylformiat chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ameisensaeure-p-menth-1-en-8-ylester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,FEMA 3052 Use and application,Ameisensaeure-p-menth-1-en-8-ylester technical grade,usp/ep/jp grade.

Related News: The market for pharmaceutical intermediates is vast and is expected to usher in new growth. Compared with the pesticide intermediate business, the market space for pharmaceutical intermediates is larger and will be the focus of the company’s future development. Terpinyl formate manufacturer In terms of business, the industrial business increased by 7.97% year-on-year, while the revenue from the trading business shrank to a certain extent. The growth rate of industrial business was significantly slower than 24% in the first half of the year, showing that the growth rate of industrial business was lower in the third quarter, which was also the main reason for the decline in the company’s operating income in the third quarter. The company’s industrial business is mainly pesticide intermediates, accounting for about 85%. The scale of the pesticide intermediate business is large and the base is high, which is putting pressure on growth. Terpinyl formate supplier Roche too has been riding high on the stock exchange this week, as investors still hope its more extensive Alzheimer’s profile could come good. Terpinyl formate vendor Currently allowed as a second-line treatment, Sarclisa is expected to have top-line data from the phase 3 IMROZ trial later this year. The trial is adding Sarclisa to a VRd cocktail of Velcade, Revlimid and dexamethasone, which has established itself as the standard-of-care first-line therapy for patients with myeloma. Terpinyl formate factory Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday.